(Q34611545)

3 August 2017

0 references

Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma (English)

1 reference

3 August 2017

0 references

1 reference

1 reference

Y Miyake

1

1 reference

3 August 2017

A Takaki

series ordinal

2

1 reference

3 August 2017

Y Iwasaki

series ordinal

3

1 reference

3 August 2017

K Yamamoto

series ordinal

4

1 reference

3 August 2017

2 September 2009

1 reference

Journal of Viral Hepatitis

3 August 2017

1 reference

3 August 2017

17

1 reference

3 August 2017

287-292

1 reference

3 August 2017

4

1 reference

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group.

3 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01181.X

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01181.X

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01181.X

Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01181.X

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01181.X

Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01181.X

10.1111/J.1365-2893.2009.01181.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference